Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
A website has been established for a Lovenox price-fixing class action lawsuit which recently saw the certification of a Class of indirect purchasers of the anticoagulant.
The website provides information regarding the class action which is scheduled to go to trial unless a settlement can be reached.
While the website is live, it is not accepting claims yet. Top Class Actions will provide claim filing instructions as soon as they become available.
Meanwhile, viewers will receive an email notice when this article is updated with more information by using a free Top Class Actions account and clicking the “Follow Article” button at the top of the post.
Plaintiffs in the Lovenox class action lawsuit motioned for Class certification in November and were subsequently granted certification by the court.
The certified Class includes individuals or entities who bought or provided payment for Lovenox or enoxaparin (the generic form of the drug) between Sept. 21, 2011 and Sept. 30, 2015.
The Class includes hospitals, third party payors, and people without insurance from the following states: Arizona, Arkansas, California, District of Columbia, Florida, Hawaii, Illinois, Iowa, Kansas, Maine, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Mexico, New York, North Carolina, North Dakota, Oregon, South Dakota, Tennessee, Utah, Vermont, West Virginia, and Wisconsin.
Class Members had until Dec. 19, 2019 to exclude themselves from the Class or object to the Lovenox class action lawsuit.
Lovenox, and the generic form enoxaparin, are blood thinning medications used to manage the risk of blood clots. The medication is particularly prescribed to people who are at risk for developing clots in the legs through a condition known as deep vein thrombosis.
According to plaintiffs in the Lovenox class action lawsuit, manufacturers Momenta Pharmaceuticals Inc. and Sandoz Inc. conspired together to artificially increase the cost of the medications. The companies allegedly achieved this by suppressing other generic forms of Lovenox – meaning that the only options for the medication were Lovenox or the generic enoxaparin.
In 2003, Momenta and Sandoz reportedly reached an agreement under which the companies would split Sandoz’s profits from generic enoxaparin. However, according to the plaintiffs, the terms of this agreement were only in effect if Sandoz was the only company to sell the generic drug.
In order to suppress the competition, Momenta allegedly secured a patent on the quality test used in the production of enoxaparin. This reportedly meant that no other companies could manufacture the generic medication without infringing on the patent.
Other companies attempted to sell the generic medication or patent the testing practice but were allegedly manipulated or sued by Momenta until they backed off – ensuring the company’s control of the market.
As a result of the agreement and subsequent suppression of competition, Momenta and Sandoz reportedly secured a monopoly which allowed them to increase the price of the medication. Plaintiffs in the Lovenox class action lawsuit claim that indirect purchasers of the products were financially harmed by the alleged price-fixing scheme.
Did you take Lovenox or the generic form of the drug, enoxaparin? Share your experiences in the comment section below.
Plaintiffs and the recently certified Class are represented by Brendan P. Glackin, Mark P. Chalos, Dean M. Harvey, Bruce W. Leppla, Katherine L. Benson, John Tate Spragens and Adam Gitlin of Lieff Cabraser Heimann & Bernstein LLP.
The Lovenox Antitrust Class Action Lawsuit is The Hospital Authority of Metropolitan Government of Nashville and Davidson County Tennessee, et al. v. Momenta Pharmaceuticals Inc., et al., Case No. 3:15-cv-01100, in the U.S. District Court for the Middle District of Tennessee.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2024 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
108 thoughts onLovenox Price-Fixing Class Action Website Is Live
During my pregnancy I was prescribed this medication. I had to purchase out of pocket due to limitations on insurance. Please add me to this claim.
I lived in Nevada in June of 2011. I had massive Bilateral PES and was on Lovenox purchased at CVS pharmacy at $100 per injection 2 times a day. Please add me to the Class Action Suit.
Add me to this please I had to take lovenox in 2011 when my daughter was born and actually had lost my home due to the cost of this med. I was also given it again in 2016 after my son was born. Then again in 2017 following another surgery , and then another. In 2018 I once again lost a home because of the shear cost of this medication.
Please add me. Have Antiphospholipid Antibody Syndrome. DX 2005 or 2006.
On because Warfarin failed after 2 years and had blood clot with high INR. Put on Enoxaparin daily 2xday and now 1xday. Copays ridiculous after moving from Kaiser insurance area and now in donut hole especially outrageous cost.
Add me. Paying out of pocket without insurance. Expensive
add me
Add me! Co-pay was ridiculous.
please add me
Add me, I took this medicine. Add me please.
Thanks
Add me